Check Cap Valuation
| CHEKDelisted Stock | USD 1.61 0.04 2.55% |
Based on Macroaxis valuation methodology, the firm appears to be overvalued. Check Cap shows a prevailing Real Value of $1.36 per share. The current price of the firm is $1.61. Our model approximates the value of Check Cap from analyzing the firm fundamentals such as return on equity of -2.26, and Current Valuation of 9.35 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Check Cap's price fluctuation is abnormally volatile at this time. Calculation of the real value of Check Cap is based on 3 months time horizon. Increasing Check Cap's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Check Cap's intrinsic value may or may not be the same as its current market price of 1.61, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.61 | Real 1.36 | Hype 1.61 | Naive 1.27 |
The intrinsic value of Check Cap's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Check Cap's stock price.
Estimating the potential upside or downside of Check Cap helps investors to forecast how Check stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Check Cap more accurately as focusing exclusively on Check Cap's fundamentals will not take into account other important factors: Check Cap Total Value Analysis
Check Cap is currently forecasted to have valuation of 9.35 M with market capitalization of 9.42 M, debt of 1.83 M, and cash on hands of 49.84 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Check Cap fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
9.35 M | 9.42 M | 1.83 M | 49.84 M |
Check Cap Asset Utilization
One of the ways to look at asset utilization of Check is to check how much profit was generated for every dollar of assets it reports. Check Cap shows a negative utilization of assets of -0.47 percent, losing $0.004658 for each dollar of assets held by the firm. Unsuccessful asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Check Cap shows how unproductive it operates for each dollar spent on its assets.Check Cap Ownership Allocation
Check Cap retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares.Check Cap Profitability Analysis
Net Loss for the year was (25.15 M) with profit before overhead, payroll, taxes, and interest of 0.About Check Cap Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Check Cap. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Check Cap based exclusively on its fundamental and basic technical indicators. By analyzing Check Cap's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Check Cap's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Check Cap. We calculate exposure to Check Cap's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Check Cap's related companies.Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. The company was incorporated in 2004 and is based in Isfiya, Israel. Check-Cap operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 81 people.
Check Cap Growth Indicators
Investing in growth stocks can be very risky. If the company such as Check Cap does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 5.9 M | |
| Shares Float | 4.4 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Consideration for investing in Check Stock
If you are still planning to invest in Check Cap check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Check Cap's history and understand the potential risks before investing.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |